DS

Digvijay Singh Shivmurti Yadav

Active Director Director DIN 10272854
DIN 10272854 First appointment Aug 2023 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Digvijay Singh Shivmurti Yadav

Data last updated:

Digvijay Singh Shivmurti Yadav is a Director at Rudbeckia Pharmaceuticals Private Limited (since 2023). The company operates in Chemicals.

DIN 10272854
Primary Designation Director
Industry Chemicals
First Appointment 09 Aug 2023
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Aug 20232022Active

Board colleagues of Digvijay Singh Shivmurti Yadav

Directorship timeline

Open interactive timeline →
Rudbeckia Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Digvijay Singh Shivmurti Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Digvijay Singh Shivmurti Yadav

Digvijay Singh Shivmurti Yadav currently holds 1 directorship: Rudbeckia Pharmaceuticals Private Limited (Director, since 09 Aug 2023).

Digvijay Singh Shivmurti Yadav was first appointed on 09 Aug 2023 as Director at Rudbeckia Pharmaceuticals Private Limited.

The current boards of Digvijay Singh Shivmurti Yadav's companies include Amit Shivmurti Yadav (Rudbeckia Pharmaceuticals Private Limited), Sher Singh (Rudbeckia Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available